Hepatocyte growth factor (HGF) is a cytokine that is produced in the placental villous core and acts in a paracrine manner on trophoblasts that express the HGF receptor Met. Because HGF stimulates the invasion of many epithelial cell types, villous core HGF could regulate placental trophoblast invasion. As preeclampsia is characterized by inadequate trophoblast invasion, we investigated the hypothesis that decreased placental HGF production is a mechanism for inadequate trophoblast invasion in this disease. Placental villous explant HGF production over 24 h was 25% lower in patients with preeclampsia (n ϭ 5; 7.29 Ϯ 0.8 ng/mL) than in normal patients (n ϭ 5; 9.76 Ϯ 0.5 ng/mL; P Ͻ 0.05). The human first trimester trophoblast cell line (ED 27 ) used in subsequent invasion studies was found to express c-met messenger ribonucleic acid by RT-PCR and Met protein by Western analysis, and underwent phosphorylation of tyrosine residues on Met with HGF exposure. A Boyden chamber invasion assay using collagen type I showed that HGF caused a specific dose-response increase in trophoblast invasion first seen at 10 ng/mL (2.2-fold increase; P Ͻ 0.05). The stimulation of trophoblast invasion by HGF may in part be due to the 2-fold induction of 92-kDa collagenase as determined by zymogram analysis of the trophoblast-conditioned medium. These studies suggest that HGF has an important role in placental trophoblast invasion through the activation of Met and the subsequent induction of 92-kDa collagenase in these cells. In addition, decreased placental production of HGF in preeclampsia provides a potential mechanism for the lack of trophoblast invasion that is seen in this pregnancy disorder. (J Clin Endocrinol Metab 84: 4092-4096, 1999) 
by Western analysis, and underwent phosphorylation of tyrosine residues on Met with HGF exposure. A Boyden chamber invasion assay using collagen type I showed that HGF caused a specific dose-response increase in trophoblast invasion first seen at 10 ng/mL (2.2-fold increase; P Ͻ 0.05). The stimulation of trophoblast invasion by HGF may in part be due to the 2-fold induction of 92-kDa collagenase as determined by zymogram analysis of the trophoblast-conditioned medium. These studies suggest that HGF has an important role in placental trophoblast invasion through the activation of Met and the subsequent induction of 92-kDa collagenase in these cells. In addition, decreased placental production of HGF in preeclampsia provides a potential mechanism for the lack of trophoblast invasion that is seen in this pregnancy disorder. (J Clin Endocrinol Metab 84: [4092] [4093] [4094] [4095] [4096] 1999) P REECLAMPSIA is a significant health problem of pregnancy, affecting approximately 7-10% of women and resulting in significant maternal and fetal morbidity and mortality. The etiology of preeclampsia is poorly understood; however, one characteristic of this disease is a lack of trophoblast invasion into the maternal decidual arteries (1) . This decrease in arterial trophoblast invasion is thought to result in placental hypoxemia with subsequent production of placental factors that lead to the development of preeclampsia (2) . Although the mechanism for decreased trophoblast invasion in preeclampsia is unknown, abnormal trophoblast integrin expression, insulin-like growth factors, and hypoxia have all been implicated in this process (3, 4) . In addition, a number of other cytokines, including transforming growth facot-␤, epidermal growth factor, and interleukin-1, have been shown to regulate trophoblast invasion in vitro (5) (6) (7) . Another cytokine that may have potential to affect trophoblast invasion is hepatocyte growth factor (HGF).
HGF is a pleiotropic cytokine that was first characterized by its ability to promote the proliferation of hepatocytes in vitro (8) . Subsequently, HGF was found to play a role in cell migration, proliferation, and morphogenesis in a number of different cell types and tissues (9) . The receptor for HGF is a tyrosine kinase receptor and is the product of the c-met protooncogene (10) . HGF is mainly produced by fibroblasts and other mesenchymal cell types (9) . The HGF receptor, Met, is primarily found in endothelial and epithelial cell types. HGF/Met interaction provides a classical example for mesenchymal cell paracrine regulation of epithelial cell function (11) . A potential role for HGF during pregnancy was first suggested in studies demonstrating high levels of HGF messenger ribonucleic acid (mRNA) expression and extractable HGF protein in human placentas (12) . In addition, HGF knockout mutations in mice are lethal to the embryo due to abnormal placental development (13) . Studies in our laboratory have shown that villous core mesenchymal cells produce HGF, whereas trophoblast express Met (14) .
As HGF is known to stimulate the migration and invasion of a number of epithelial cell types, we hypothesized that placental villous core mesenchymal cell production of HGF may regulate trophoblast invasion. Consequently, this study was designed to test the hypothesis that decreased placental HGF production is a potential mechanism for shallow trophoblast invasion in preeclampsia.
Materials and Methods

Culture of placental villous explants
Placentas were obtained immediately after delivery from normal (n ϭ 5) and preeclamptic (n ϭ 5) pregnancies (35-40 weeks gestation). Preeclampsia was defined as maternal blood pressure of more than 140/90 mm Hg with proteinuria (Ͼ300 mg/24 h or ϩ2 on single urine sample) and edema. Placental villous explants were cultured as previously described (14) . Immediately after obtaining the placenta, placental villi were dissected free from the decidua basalis, minced into small pieces, and rinsed free of blood. The placental villi (350 mg wet weight) were cultured in duplicate in 5 mL DMEM with 10 mmol l-glutamine, 100 mIU/mL penicillin, and 100 mg/mL streptomycin, pH 7.4 (Sigma Chemical Co., St. Louis, MO) for 24 h, and the medium was stored at Ϫ20 C until assayed for HGF.
Enzyme-linked immunosorbant assay (ELISA) for HGF
HGF in placental villous explant-conditioned medium was quantified by a sandwich ELISA for human HGF as previously described (14) . Polystyrene 96-well plates (Costar, Cambridge, MA) were coated with mouse monoclonal antibody to human HGF (R&D Systems, Minneapolis, MN) at a concentration of 2 g/mL in 0.2 mol/L Na 2 CO 3 buffer, pH 9.6, for 24 h at 4 C. The plates were washed with phosphate-buffered saline with 0.05% Tween-20 (PBST) and blocked with 1% BSA in 0.2 mol/L Na 2 CO 3 buffer, pH 9.6, for 1 h at 37C. After washing the plates with PBST, 100 L of the conditioned medium samples or human recombinant HGF standard (R&D Systems) in triplicate were added to the plates and incubated at 4 C overnight. The plates were then washed with PBST and incubated with 100 L goat anti-HGF antibody (R&D Systems) at a concentration of 2 g/mL in PBST for 2 h at room temperature. The plates were washed with PBST and then incubated with 100 L of a 1:15,000 dilution of peroxidase-conjugated mouse antigoat IgG (Pierce Chemical Co., Rockford, IL) for 1 h at room temperature. The wells were washed with PBST and developed with a 0.1% O-phenylenediamine dihydrochloride substrate (Sigma Chemical Co.) in 0.1 mol/L citric acid buffer, pH 4.5, with 0.005% H 2 O 2 for 20 min at room temperature. The reaction was stopped by the addition of an equal volume of 2 mol/L H 2 SO 4 , and the plates were read at 490 mm in a V-max Kinetic Microplate Reader (Molecular Devices, Palo Alto, CA). The assay sensitivity and range were 240 pg/mL to 60 ng/mL. To validate the assay, samples that were either serially diluted or to which known amounts of the HGF standard were added were compared to the standard curve to demonstrate appropriate parallelism. The within-assay coefficient of variation was 4% at 20 ng/mL, 7% at 4 ng/mL, and 15% at 0.8 ng/mL. All sample comparisons were run in the same assay to eliminate between assay variability.
ED 27 trophoblast cells
The ED 27 trophoblast cell line used in these studies was derived from a prenatal diagnostic first trimester chorionic villous sample. The pregnancy resulted in a normal male infant. This cell line produces estradiol and progesterone, expresses placental alkaline phosphatase, produces low amounts of hCG, is positive for cytokeratin type 8, and is negative for vimentin (15) .
RT-PCR for Met
RT-PCR was performed by isolating total RNA from the human first trimester trophoblast cell line, ED 27 , using the acid guanidinium isothiocyanate-phenol-chloroform extraction method. First strand synthesis was performed on 1 g total RNA using specific human Met 3Ј-primers and SuperScript II ribonuclease HG reverse transcriptase (Life Technologies, Inc., Gaithersburg, MD). Yeast RNA (Sigma Chemical Co.) was used as a negative control. The complementary DNA was amplified using the GeneAmp system of DNA amplification (Perkin Elmer Corp./ Cetus, Norwalk, CT). Samples were incubated in a thermocycler (M. J. Research, Inc., Watertown, MA) for 30 cycles after the addition of the 5Ј-primers and Taq polymerase. Denaturing was carried out at 94 C for 1 min, followed by primer annealing at 58 C (Met) for 1 min and primer extension at 72 C for 2 min. The PCR products were then separated by size in a 1.5% agarose gel by electrophoresis and stained with ethidium bromide.
The primers were synthesized in the Nucleic Acid Core Facility at Virginia Commonwealth University using a PE Applied Biosystems 380 A DNA synthesizer (Foster City, CA). The sequences of the Met primers were 5Ј-226 tcctcgtgctcctgtttacc 245 and 3Ј-865 tctttcgtttcctttagccttc 844.
Western immunoblotting for Met
The ED 27 cell line was homogenized in RIPA buffer (5 mmol/L Tris, 150 mmol/L NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 0.1 mmol/L ethylenediamine tetraacetate, 0.1 mmol/L phenylmethylsulfonylfluoride, and 2 g/mL aprotinin, pH 7.5). The homogenate was clarified by centrifugation, and the protein concentration of the supernatant was determined in a Coomassie protein assay using albumin as the standard (Pierce Chemical Co.). The soluble protein extract (10 g) was electrophoresed through a denaturing 7.5% SDSpolyacrylamide gel and transferred to a nitrocellulose membrane. The membrane was blocked with 5% nonfat dry milk in TBST (100 mmol/L Tris, 0.9% NaCl, and 0.05% Tween-20, pH 7.4) for 1 h. The membrane was then incubated for 1 h with 2 g/mL rabbit IgG antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) developed against a synthetic Met peptide. Development of the Western blots was performed using the Amersham Pharmacia Biotech ECL system (Amersham Pharmacia Biotech, Arlington Heights, IL).
Immunoprecipitation/Western immunoblotting of Met for phosphorylation of tyrosines
ED 27 cells were grown in DMEM-Ham's F-12 with 10% FBS until semiconfluent. The medium was replaced with serum-free DMEMHam's F-12 and cultured for 24 h. ED 27 cells were then exposed to HGF (50 ng/mL) for either 15 or 30 min. The cells were lysed in RIPA buffer with the addition of NaVO 4 at 1 mmol/L. The homogenate was clarified by centrifugation, and the protein concentration of the supernatant was determined in a Coomassie protein assay using albumin as the standard (Pierce Chemical Co.).
For immunoprecipitation of Met, 100 g total cellular protein was incubated with 1 g anti-Met rabbit polyclonal antibody (Santa Cruz Biotechnology, Inc.) overnight at 4 C, followed by the addition of protein G-agarose (Sigma Chemical Co.) for 2 h at 4 C. The immunoprecipitated receptor/protein G-agarose complexes were then washed extensively with RIPA buffer and boiled for 2 min in denaturing loading buffer. The protein samples were electrophoresed through a denaturing 7.5% SDSpolyacrylamide gel and transferred to a nitrocellulose membrane. The membrane was blocked with 1% BSA in TBST for 1 h. The membrane was then incubated overnight at 4 C with 2 g/mL horseradish peroxidase-conjugated RC20 monoclonal antiphosphotyrosine antibody (Transduction Laboratories, Lexington, KY). Development of the Western blots was performed using the Amersham Pharmacia Biotech ECL system. Control for specificity of the Western blots included substituting the specific Met antibody with nonspecific IgG at the same concentration.
ED 27 invasion assay
The Boyden chamber invasion assay was performed by coating porous membrane (8-mm) culture well inserts with 25 g rat tail collagen type 1 (Collaborative Biomedical Products, Bedford, MA). The ED 27 cells (10 5 cells/well) were then added on top of the collagen-coated membrane insert and incubated in DMEM-Ham's F-12 medium with 10% FBS for 72 h with the addition of 0, 0.1, 1.0, 10, or 100 ng/mL of HGF (n ϭ 4 wells/dose). The inserts were fixed and stained with crystal violet in methanol. The side of the membrane insert with the collagen coating and noninvading ED 27 cells was gently scraped away with a cotton swab, and the opposite side of the membrane was examined to determine cell invasion. This assay was quantified by counting the number of ED 27 cells that had invaded the collagen-coated membranes. To demonstrate the specificity of the HGF-induced invasion, the invasion assay was also performed with or without the addition of neutralizing antibody to HGF (R&D Systems) at a concentration of 20 g/mL in the presence of 10 ng/mL HGF. One-way ANOVA was used to analyze the Boyden chamber invasion assays.
Zymography for 92-kDa collagenase
Confluent ED 27 cells were cultured in 35-mm 2 dishes for 48 h in 5 mL serum-free DMEM-Ham's F-12 with the addition of either 0 or 10 ng/mL HGF. The conditioned medium was then collected and concentrated 20-fold using Centricon concentrators (Amicon, Beverly, MA). Nonreducing 10% polyacrylamide gels supplemented with 1% gelatin were used to determine the proteolytic activity of the conditioned medium. After electrophoresis, the gels were washed in renaturing buffer (2.5% Triton X-100) and once in developing buffer (10 mmol/L Tris base, 40 mmol/L Tris-HCl, 20 mmol/L NaCl, 5 mmol/L CaCl 2 , and 0.02% 23 BRIJ35; Novex, San Diego, CA). Gels were incubated in fresh developing buffer overnight at 37 C. Gels were stained in 0.05% Coomassie blue with 30% methanol and 10% glacial acetic acid for 3 h and then destained in 30% methanol and 10% glacial acetic acid as needed. Prestained molecular mass standards (Bio-Rad Laboratories, Inc., Hercules, CA) were used to determine the molecular mass of proteolytic activity.
Results
Our initial experiments found significant differences in the production and secretion of HGF by normal and preeclamptic placentas (Fig. 1) . The secretion of HGF into the culture medium by placental villous explants over 24 h was 25% less in placentas from preeclamptic pregnancies (7.29 Ϯ 0.8 ng/ mL) compared to that in placentas from normal pregnancies (9.76 Ϯ 0.5 ng/mL; P Ͻ 0.05).
To determine the potential role of HGF/Met in trophoblast invasion, we characterized the first trimester human trophoblast cell line ED 27 for Met expression. As shown in Fig. 2 , ED 27 cells express c-met RNA similarly to freshly isolated first trimester trophoblast cells, as demonstrated by the appropriate size 639-bp band. Similar to isolated trophoblast, ED 27 cells show no evidence of HGF mRNA expression by RT-PCR (data not shown). Western blot analysis for Met protein demonstrated that the appropriate size 140-kDa band was expressed in ED 27 cells (Fig. 3) . Finally, the addition of HGF to the ED 27 cells resulted in the phosphorylation of tyrosine residues on Met within 15 min of the addition of HGF, whereas no evidence of phosphorylation was seen without the presence of HGF (Fig. 4) . These findings show that ED 27 cells produce and express a functional Met receptor for HGF.
To evaluate the role of Met activation by HGF in trophoblast invasion, Boyden chamber invasion assays were performed. As shown in Fig. 5 , HGF caused a specific doseresponse increase in ED 27 cell invasion. This stimulatory effect on invasion was first seen at 10 ng/mL HGF (P Ͻ 0.01) and was approximately 3.5-fold higher at 100 ng/mL HGF. The stimulation of trophoblast invasion was readily apparent upon microscopic visual examination of the bottom side of the Boyden chamber membrane (Fig. 6) . The specificity of HGF action on trophoblast invasion was further demonstrated by the complete inhibition of HGF-stimulated trophoblast invasion by HGF neutralizing antibody (Figs. 6  and 7) .
To determine whether increased collagenase production is a mechanism of HGF stimulation of ED 27 trophoblast invasion, zymogram analysis of ED 27 cell-conditioned medium was performed. Conditioned medium from ED 27 cells treated with 10 ng/mL HGF showed a 2-fold increase in 92-kDa collagenase compared to untreated control cells (Fig.  8) . No evidence of collagenases of other molecular sizes were detected in these studies. These experiments were repeated three times with similar results.
Discussion
The findings from this study demonstrate for the first time that HGF stimulates the invasion of trophoblast through the FIG. 1. Placental villous explants were cultured for 24 h in serumfree DMEM, and the medium was assayed for HGF by ELISA. Placental HGF production was 25% lower (*, P Ͻ 0.05) in patients with preeclampsia (PE) compared to that in normal patients (NL). activation of Met present on these cells. HGF was found to increase the expression of 92-kDa collagenase by these trophoblast cells and provide a mechanism by which HGF may enhance trophoblast invasion. ED 27 trophoblast cells were used as a model for trophoblast invasion in these studies, because these cells express Met and produce 92-kDa collagenase, similarly to freshly isolated first trimester villous trophoblast. Although abnormalities in trophoblast invasion in preeclampsia may not occur until after the first trimester, trophoblasts from all gestational ages express Met and collagenase similar to ED 27 trophoblasts (14, 16) . The stimulation of trophoblast invasion and induction of collagenase production by HGF is consistent with the action of HGF in several different epithelial carcinomas (17, 18) . HGF is also known as "scatter factor" for its ability to induce motility of epithelial cells in culture (2) . Although the ability of HGF to induce motility in trophoblast cells was not directly tested in this study, it is possible that trophoblast invasion may have been enhanced by the stimulation of trophoblast motility.
HGF may play an important role in placental trophoblast invasion through the activation of Met and the subsequent induction of 92-kDa collagenase in these cells. The 2-fold induction of 92-kDa collagenase in ED 27 trophoblast by HGF is comparable to IL-1 which stimulates a 3-fold induction of 92-kDa collagenase in isolated villous trophoblast (19) . Our laboratory and others have previously shown that the major site of placental HGF production is the villous core, specifically villous core mesenchymal cells (14, 20) . In placental villi, the HGF receptor Met, is expressed mainly in cytotrophoblast. These findings in addition to studies showing the stimulation of trophoblast proliferation in response to HGF has suggested an important role for villous core HGF in the regulation of trophoblast proliferation (21) . However, our laboratory has also shown that Met is localized to invasive trophoblast at the site of anchoring villi (22) . As the current study shows that HGF stimulates trophoblast invasion in vitro, HGF produced and secreted by the villous core may play a role in the regulation of trophoblast invasion in vivo. This hypothesis of a villous core paracrine factor regulating trophoblast invasion helps explain why the majority of trophoblasts do not invade a great distance from the placenta into the uterus during normal pregnancy. As trophoblasts migrate further away from the villous core, there would be lower concentrations of villous core HGF present to stimulate trophoblast invasion.
One of the pathological findings associated with preeclampsia is the presence of shallow trophoblast invasion. This study demonstrated decreased placental production and secretion of HGF in placental villi from pregnancies complicated by preeclampsia. These findings are consistent with a previous study that showed decreased HGF mRNA expression and tissue-extractable HGF protein in placentas from women with preeclampsia (20) . It is possible that the adverse effects of preeclampsia result in the decreased expression of placental HGF and are not a cause of preeclampsia. However, as the current study has shown that HGF stimulates trophoblast invasion, these findings suggest the possibility that decreased placental HGF production in pregnancies complicated by preeclampsia may be a potential mechanism for the shallow trophoblast invasion seen in this pregnancy disorder. 27 trophoblast-conditioned medium after culture for 48 h in either the presence or absence of 10 ng/mL HGF. Dilutions of the conditioned medium (either 1:2 or 1:4) were electrophoresed through a nonreducing 10% polyacrylamide gel supplemented with 1% gelatin. Proteolytic activity was noted for the 92-kDa collagenase. The addition of HGF resulted in a 2-fold induction of the 92-kDa collagenase.
FIG. 8. Zymogram analysis of ED
